News
The rapidly expanding landscape of cannabinoids now includes several novel compounds beyond traditional THC and CBD. This article provides a detailed analysis of six emerging cannabinoids: HHCP (9(R)-Hexahydrocannabiphorol), HHCPO (9(R)-Hexahydrocannabiphorol Acetate), THCP (Δ9-Tetrahydrocannabiphorol, CAS 54763-99-4), Δ8-THCP (Delta-8-Tetrahydrocannabiphorol, CAS 51768-60-6), HHCV (9(R)-Hexahydrocannabivarin), and THCV (Δ9-Tetrahydrocannabivarin, CAS 31262-37-0). Each of these compounds is chemically related to THC (Δ9-tetrahydrocannabinol) but with structural modifications that confer unique potency, effects, and legal considerations. Below, we examine each cannabinoid in turn, covering their chemical identity, pharmacology, health effects, safety profile, dosing, contraindications, and legal status by region.
